Capstone Investment Advisors »

Immunome shares owned by Capstone Investment Advisors

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by Capstone Investment Advisors from 13F filings

Historical chart of Capstone Investment Advisors investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by Capstone Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $321k 15k 21.87
2024-03-31 $1.0M 42k 24.68

More positions owned by Capstone Investment Advisors

Invesco Qqq Tr Unit Ser 1 (QQQ)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Amazon (AMZN)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr China Lg-cap Etf (FXI)
Alphabet Cap Stk Cl A (GOOGL)
Lumentum Hldgs Note 1.500%12/1 (Principal)
Meta Platforms Cl A (META)
Select Sector Spdr Tr State Street Fin Call Option (XLF)
Western Digital Corp Note 3.000%11/1 (Principal)

View all positions for Capstone Investment Advisors

Top funds holding Immunome

FMR
T. Rowe Price Investment Management
BlackRock
Vanguard Group
Redmile Group
PRIMECAP Management Company
Vanguard Capital Management
State Street Corporation
Driehaus Capital Management
Enavate Sciences GP
Morgan Stanley
Geode Capital Management
Leucadia National Corporation
Sofinnova Ventures
Woodline Partners

View all funds holding Immunome